Few ideas in human biology are as firmly settled as this one: a woman is born with a lifetime's supply of eggs, and once they run out, they are gone for good. It is the reasoning behind menopause and much of what we understand about the female reproductive clock. But a strand of research, building quietly for about 20 years, is prodding at that certainty — and suggesting the story may be more complicated, Scientific American reported.
The dogma, and the first crack
The textbook view took hold roughly 70 years ago: female mammals possess a finite ovarian reserve, fixed before or shortly after birth, that steadily declines. In 2004, the reproductive biologist Jonathan Tilly, now at Northeastern University, published a paper in the journal Nature questioning whether the numbers actually added up, arguing that the rate at which eggs are lost seemed hard to reconcile with a strictly fixed pool. It was a direct challenge to a long-unquestioned assumption, and it drew immediate pushback.
What followed was two decades of accumulating, and disputed, evidence.
What the research claims
At the center of the debate are what some scientists call oogonial stem cells — cells said to reside in adult ovaries that, under the right conditions, might give rise to new immature egg cells. In 2009, researchers in Shanghai reported isolating such cells from adult mice. By 2012, Tilly's team said it had identified comparable cells in adult human ovaries. Work has continued since: researchers have reported that genetically engineered mouse cells could yield viable offspring, and, more recently, that these cells persist into old age but lose their regenerative capacity as key genes switch off.
The University of Edinburgh biologist Evelyn Telfer has collaborated on studies of human ovarian tissue, reporting that certain cells can be coaxed to develop into egg-like structures. Taken together, proponents argue, the findings point to a reproductive system that is less static than the textbooks describe.
Why many scientists remain skeptical
The claims are far from universally accepted, and for good reason. A central question is viability: even if adult ovaries contain such cells, it is not established that they can produce genuine, functional human eggs capable of becoming healthy embryos. Some researchers, including Aaron Hsueh of Stanford University, have criticized the methods used to identify the cells — particularly the antibodies used to tag them — raising the possibility that what was detected is not what it was claimed to be.
Tilly, for his part, points to a substantial body of supportive work, noting that many peer-reviewed papers now report the existence of these cells. But the disagreement is genuine, and it turns on hard technical questions about what has actually been observed. The ovary is a complex organ, its supporting tissue grows more fibrous and scarred with age, and disentangling a real regenerative process from an artifact of the experiment is difficult.
Why it matters — and the caution required
If the more radical interpretation proves correct, the implications would be significant. A source of new eggs in adult ovaries could, in principle, open avenues for treating infertility or slowing aspects of reproductive aging. That is exactly why the topic attracts both excitement and unusually close scrutiny: the potential payoff is large, and so is the risk of overpromising.
For now, the responsible reading is that a long-standing dogma is being seriously questioned, not overturned. The evidence is intriguing and growing, but contested, and lab-grown breakthroughs remain a long way from proven human therapies. What is clear is that a rule once treated as beyond doubt is now a live scientific argument — a reminder that even the most familiar textbook facts are, in the end, provisional.
